TABLE 5.
Characteristic | Group I (n = 108) | Group II (n = 250) | Group III (n = 147) |
---|---|---|---|
Primary cancer site | |||
Breast | 36 (33.3%) | 19 (7.6%) | 0 (0.0%) |
Other | 72 (66.7%) | 231 (92.4%) | 147 (100.0%) |
Site of metastases | |||
Bone only | 84 (77.8%) | 66 (26.4%) | 0 (0.0%) |
Other | 24 (22.2%) | 184 (73.6%) | 147 (100.0%) |
KPS | |||
>60 | 99 (91.7%) | 165 (66.0%) | 0 (0.0%) |
≤60 | 9 (8.3%) | 85 (34.0%) | 147 (100.0%) |
Time of death (d) | |||
Within 0‐30 | 30 (27.8%) | 90 (36.0%) | 73 (49.7%) |
Within 31‐60 | 5 (4.6%) | 11 (4.4%) | 12 (8.2%) |
Within 61‐90 | 73 (67.6%) | 149 (59.6%) | 62 (42.2%) |
Abbreviation: KPS, Karnofsky Performance Status. [Correction added on 22 July 2020, after first online publication: The data under the subheading 'KPS' have been corrected in this version]